| Ayse S Durgun, MD | |
|
285 Sills Rd Ste B, East Patchogue, NY 11772-4869 | |
| (631) 654-4577 | |
| Not Available |
| Full Name | Ayse S Durgun |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 25 Years |
| Location | 285 Sills Rd Ste B, East Patchogue, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467758946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 266347 (New York) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 266347 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Long Island Community Hospital | Patchogue, NY | Hospital |
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
| Entity Name | Amityville Pulmonology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154423622 PECOS PAC ID: 2567471139 Enrollment ID: O20060410000225 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
| Entity Name | Coney Island Medical Practice Plan, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386951762 PECOS PAC ID: 5496944803 Enrollment ID: O20110114000660 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayse S Durgun, MD 450 Clarkson Ave # 19, Brooklyn, NY 11203-2012 Ph: (718) 270-1000 | Ayse S Durgun, MD 285 Sills Rd Ste B, East Patchogue, NY 11772-4869 Ph: (631) 654-4577 |
News Archive
New research published today in the journal Environmental Health Perspectives from Environmental Defense Fund and the George Washington University shows air pollution takes an enormous toll on health in the San Francisco Bay Area, and the impacts vary dramatically within neighborhoods.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
"We know from previous studies that patients with symptomatic mitral regurgitation are at increased risk of death, but for those without symptoms the picture has been murkier," says Maurice Enriquez-Sarano, M.D., the Mayo Clinic cardiologist who led the study. "In this study we followed a large population of asymptomatic patients prospectively to identify keys to improved long-term outcomes, and to determine when patients should consider surgery."
IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.
› Verified 9 days ago
Joel Myladoor Chandy, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Patchogue Yaphank Rd, East Patchogue, NY 11772 Phone: 631-289-0300 | |
Qazi Qaisar Afzal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 285 Sills Rd, Building 7, Suite B, East Patchogue, NY 11772 Phone: 631-654-4577 Fax: 631-654-3391 | |
Amit Sankar Mandal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd Ste 201, East Patchogue, NY 11772 Phone: 631-475-6900 | |
Shahriar Joseph Khalili, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 285 Sills Road, Building #14, East Patchogue, NY 11772 Phone: 631-447-8300 Fax: 631-447-8872 | |
Ajish Pillai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Patchogue Yaphank Rd Ste C, East Patchogue, NY 11772 Phone: 215-762-7000 | |
Robert M Chernaik, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 285 Sills Rd Bldg 4d, East Patchogue, NY 11772 Phone: 631-654-1800 Fax: 631-240-9181 | |
Dean J Babich, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Patchogue Yaphank Rd, Suite F, East Patchogue, NY 11772 Phone: 631-654-8755 Fax: 631-654-8709 |